Suppr超能文献

结缔组织病患者血清KL-6水平与间质性肺疾病的关联:一项横断面研究。

Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.

作者信息

Oguz Ekin Oktay, Kucuksahin Orhan, Turgay Murat, Yildizgoren Mustafa Turgut, Ates Askin, Demir Nalan, Kumbasar Ozlem Ozdemir, Kinikli Gulay, Duzgun Nursen

机构信息

Department of Internal Medicine, Ankara University Medical School, Ankara, Turkey.

Department of Rheumatology, Ankara University Medical School, Ankara, Turkey.

出版信息

Clin Rheumatol. 2016 Mar;35(3):663-6. doi: 10.1007/s10067-015-3167-8. Epub 2016 Jan 13.

Abstract

It was aimed to evaluate KL-6 glycoprotein levels to determine if it may be a diagnostic marker for the connective tissue diseases (CTDs) predicting CTD-related interstitial lung diseases (ILDs) (CTD-ILD) development and to examine if there was a difference between patients and healthy controls. The study included 113 patients with CTD (45 CTD without lung involvement, 68 CTD-ILD) and 45 healthy control subjects. KL-6 glycoprotein levels were analyzed with ELISA in patients and the control group. The relationship between KL-6 glycoprotein levels and CTD-ILD was assessed. In the comparison of all the groups in the study, significantly higher levels of KL-6 were determined in the CTD-ILD group than in either the CTD without pulmonary involvement group or the healthy control group (p < 0.008 and p < 0.001, respectively). There was no statistically significant difference between the KL-6 levels in the healthy control group and the CTD without pulmonary involvement group (p = 0.289). The KL-6 levels did not differ significantly according to the connective tissue diseases in the diagnostic groups (systemic lupus erythematosus, Sjögren's syndrome, rheumatoid arthritis, mixed connective tissue disease, scleroderma, polymyositis/ dermatomyositis). In the healthy control group, there was a statistically significant difference between KL-6 levels in smokers and non-smokers. Smokers had significantly higher serum KL-6 levels compared with non-smokers (p < 0.05). There was no statistically significant difference between smoking status (pack-year) and serum KL-6 levels. There was no statistically significant correlation between serum KL-6 levels and time since diagnosis of CTD and CTD-ILD. The level of KL-6 as a predictive factor could be used to identify the clinical development of ILD before it is detected on imaging modality. Further prospective clinical studies are needed to define whether levels of KL-6 might have prognostic value or might predict progressive ILD.

摘要

旨在评估KL-6糖蛋白水平,以确定其是否可能作为结缔组织病(CTD)的诊断标志物,预测CTD相关间质性肺病(ILD)(CTD-ILD)的发展,并检查患者与健康对照之间是否存在差异。该研究纳入了113例CTD患者(45例无肺部受累的CTD,68例CTD-ILD)和45例健康对照者。采用酶联免疫吸附测定法(ELISA)分析患者和对照组的KL-6糖蛋白水平。评估KL-6糖蛋白水平与CTD-ILD之间的关系。在该研究所有组别的比较中,CTD-ILD组的KL-6水平显著高于无肺部受累的CTD组或健康对照组(分别为p < 0.008和p < 0.001)。健康对照组和无肺部受累的CTD组之间的KL-6水平无统计学显著差异(p = 0.289)。诊断组(系统性红斑狼疮、干燥综合征、类风湿关节炎、混合性结缔组织病、硬皮病、多发性肌炎/皮肌炎)中,KL-6水平根据结缔组织病无显著差异。在健康对照组中,吸烟者和非吸烟者的KL-6水平存在统计学显著差异。吸烟者的血清KL-6水平显著高于非吸烟者(p < 0.05)。吸烟状况(包年)与血清KL-6水平之间无统计学显著差异。血清KL-6水平与CTD和CTD-ILD诊断后的时间无统计学显著相关性。KL-6水平作为预测因子,可用于在影像学检查发现ILD之前识别其临床发展情况。需要进一步的前瞻性临床研究来确定KL-6水平是否具有预后价值或是否可预测ILD的进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验